Commercializing Nanomedicine ─ Industrial Applications, Patents, and Ethics

Following two decades of tremendous advancements in biomedical research, nanomedicine has now spread from labs to hospital wards and is already starting to redesign the state of the art in clinical practice. This book covers the latest trends in nanotechnology-driven translational medicine while providing the readers with the need-to-know ethical and legal factors that are accompanying this epochal shift in the way medicine is conceived and practiced across the globe. Edited by prominent nanotechnology researchers, surgeons, and entrepreneurs, this book will appeal to anyone involved in cutting-edge nanomedicine.

Luca Escoffier graduated in law from the University of Parma (Italy) and then earned a master of laws in intellectual property law in 2003 (World Intellectual Property Organization). After spending several years at law firms and an Italian nano-biotech company, he moved to Seattle in 2008 to work as a visiting lecturer at the University of Washington. There, he also earned a certificate in business administration from the Foster Business School in 2010. Escoffier is a fellow of the Stanford-Vienna Transatlantic Technology Law Forum, invited researcher at Waseda University, and a Singularity University alumnus (GSP’10). He is a cofounder of Innoventually, one the most innovative Open Innovation online portals, and works as a cofounder, mentor, and advisor for several companies around the world.

Mario Ganau is a neurosurgeon with vast knowledge about the application of innovation technology in neuroscience. He is a global clinical scholar in clinical trials (Harvard Medical School, USA) and holds a PhD in nanotechnology (University of Trieste, Italy), CAS in management of biotech medtech and pharma ventures (Ecole polytechnique federale de Lausanne, Switzerland), DU in neuropharmacology (Universite Pierre et Marie Curie, France), MSBM in biological sciences (Universite Claude Bernard Lyon 1, France), and DIU in robotic surgery (Universite Henri Poincare, France). Recently, he started his second PhD in biomedical engineering (University of Cagliari, Italy), spending periods as a visiting researcher at the Kennedy Institute of Ethics (Georgetown University, USA) and the Institute for Drug Research (Hebrew University of Jerusalem, Israel). Featured in 2012 as "Working Class Hero" byWired Magazine Italia, he received the 2013 TOYP award for medical research by JCI, Italy, and a nomination for the Wired Audi Innovation Award 2014. Dr. Ganau is a cofounder and partner of iStarter, a startup incubator based in Turin and London.

Julielynn Wong combines knowledge and real-world expertise in technology and innovation for healthcare. She founded the Center for Innovative Technologies and Public Health, whose mission is to educate leaders on applying technologies to address the greatest challenges in healthcare. She worked at San Francisco-based Skoll Global Threats Fund to build "Flu Near You," the world’s largest crowd-sourced flu tracking and vaccine locator platform. She trained in space medicine at NASA Johnson Space Center and created 3D4MD, a digital platform of 3D printable medical supplies to deliver healthcare in the most challenging places to those who need it the most. Dr. Wong serves as a faculty lecturer at Singularity University and cofounded its Digital Health and Wellness Program. She specializes in medical communications, having reported for ABC World News, Forbes, and the Huffington Post, and made numerous television appearances, including an Emmy-nominated series on Discovery Channel. Her mission is to empower medical experts to harness multimedia platforms to positively impact billions of people.